Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04112381 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04112381 · ClinicalTrials.gov record · last posted 2025-05-01

Bilateral Treatment of Medication Refractory Essential Tremor

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started2020-06-30
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 1, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
The purpose of this study is to see if the MR-guided focused ultrasound (MRgFUS) thalamotomy procedure can be performed on both sides of the brain safely and effectively to reduce bilateral tremor.

Amendment record 13 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 13 times since 2019-09-30; most recent amendment 2025-04-30. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2021-10-08
Status change Recruiting→Active, Not Recruitingv10
2020-03-12
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT04112381
Lead Sponsor InSightec
Conditions Essential Tremor
Enrollment 51 participants
Start Date 2020-06-30
Primary Completion 2026-03 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-01